![Medicover, Audiocast with teleconference, Q4'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/ff97e9c5-25d3-4894-bc5f-2e30e4f5007f.png)
Medicover
207
SEK
-1.43 %
MCOV B
NASDAQ Stockholm
Health Care Providers
Health Care
Less than 1K followers
-1.43%
+7.59%
+7.81%
+15%
+12.62%
+33.03%
-26.73%
+81.9%
+216.03%
Medicover is active in healthcare. The business activities are focused on service services within health care and diagnostics. The company offers primary and specialized care, financing solutions and laboratory tests in pathology. The main market is found around the European market with research institutes as the dominant customer base. Medicover was founded in 1995 and has its headquarters in Stockholm.
Read moreMarket cap
31.78B SEK
Turnover
45.14M SEK
Revenue
19.44B
EBIT %
3.52 %
P/E
157.56
Dividend yield-%
0.65 %
Financial calendar
12.2
2025
Annual report '24
29.4
2025
Interim report Q1'25
29.4
2025
General meeting '25
ShowingAll content types
![Medicover, Audiocast with teleconference, Q4'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/ff97e9c5-25d3-4894-bc5f-2e30e4f5007f.png)
Medicover: Year-end report January-December 2024
John Stubbington appointed new CEO of Medicover from 1 May 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Invitation to Medicover's results presentation for Q4 2024
Medicover to exit Hungary fully
Medicover's Social Finance Investor Report is now published
Medicover to evaluate a potential separate listing in india
![Medicover, Audiocast with teleconference, Q3'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/9d9a36a7-cc38-4bf2-b030-9dcf86e1e03d.png)
Medicover, Audiocast with teleconference, Q3'24
Medicover: Interim report July-September 2024
Invitation to Medicover's results presentation for Q3 2024
Medicover's nomination committee for the AGM 2025
Anand Patel new Chief Financial Officer of Medicover
![Medicover, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/f6d564cc-4c0c-4e3f-8ed6-ee9c53bc33c0.png)